CD274 and neoplasm: Tumor cells use mechanisms that act via the PD-L1 or CTLA-4 program, a blockage of co-stimulation to activate T cells, and the recruitment of tumor-associated macrophages and marrow-derived suppressor cells (MDSCs), to achieve immune suppression [88].